期刊文献+

重症肌无力与多基因多位点单核苷酸多态性的相关性研究 被引量:2

Correlation between single nucleotide polymorphisms of multi-loci and multi-genes and myasthenia gravis
原文传递
导出
摘要 目的探讨重症肌无力(myasthenia gravis,MG)与PTPN22+1858C/T、CTLA4(+49A/G;-1772C/T;-1661A/G)、KRAS(rs9226)、BCL2(rs4987855)、IGF1R(rs34804698)基因多态性的相关性。方法选取2011年7月至2015年6月于哈尔滨医科大学附属第二医院住院就诊的76例MG患者及59名健康对照为研究对象,采用聚合酶链反应一限制性片段长度多态性(PCR—RFLP)技术,对PTPN22+1858C/T、CTLA-4(+49A/G;-1772C/T;-1661A/G)、KRAS(rs9226)、BCL2(rs4987855)、IGF 1R(rs34804698)基因多态性进行分型。结果CTLA-4第1外显子+49位点即m231775在MG组中G等位基因频率(57.9%)明显高于对照组(22.1%),差异有统计学意义(χ^2=35.252,P=0.000)。G等位基因在胸腺瘤亚组中频率(25.6%)明显高于其余两组(胸腺增生组:13.8%;胸腺未增生组:18.4%),差异具有统计学意义(χ2=7.564,P=0.006;χ2=7.155,P=0.007)。CTLA-4基因启动区-1772位点即rs733618在MG组中C等位基因频率(43.4%)明显高于对照组(31.4%),差异有统计学意义(χ^2=4.098,P=0.043)。C等位基因频率在胸腺瘤亚组(19.7%)中高于其余亚组(胸腺增生组:9.86%;胸腺未增生组:13.8%),差异有统计学意义(χ^2=5.331,P=0.021;χ^2=4.411,P=0.036)。其余位点等位基因频率在MG组及对照组间差异无统计学意义。结论MG与CTLA-4(+49A/G、-1772C/T)多态性相关,而与PTPN、KRAS(rs9226)、BCL2(rs4987855)、IGF 1R(rs34804698)基因多态性无明显相关性。 Objective To investigate the association between myasthenia gravis (MG) and single nucleotide polymorphisms (SNPs) of PTPN22 + 1858C/T, CTLA-4 ( + 49A/G; - 1772C/T; - 1661A/ G), KRAS(rs9226), BCL2(rs4987855) and IGF-1R(rs34804698) genes. Methods Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was adopted to detect the gene types of SNPs in 76 MG patients who were enrolled in the Second Affiliated Hospital of Harbin Medical University from July 2011 to June 2015 and 59 healthy blood donors. Results In MG patients, the frequences of CTLA-4 +49A/G(rs231775) (57.9%) and - 1772C/T (rs733618) (43.4%) were higher than that in the healthy controls (22. 1% ) ( χ^2 = 35. 252, P = 0. 000; χ^2 = 4. 098, P = 0. 043 ). The frequence of CTLA- 4 +49A/G in MG patients combined with thymoma (25.6%) was higher than other subgroups (thymic hyperplasia group: 13. 8% ; normal thymus group: 18.4% ) ( χ^2 = 7. 564, P = 0. 006; χ^2 = 7. 155, P = 0. 007). Meanwhile, the frequence of the C-1772 allele was higher in thymoma group (19. 7% ) compared with other two groups (thymic hyperplasia group: 9. 86% ; normal thymus group: 13.8 % ) (χ^2 = 5. 331,P = 0. 021 ;χ^2 = 4. 411, P= 0. 036). However, the other SNPs were not associated with the risk of MG. Conclusion There are associations of MG with CTLA-4 + 49A/G and - 1772C/T SNPs, but not with PTPN, KRAS, BC12 and IGF-1R SNPs.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2016年第4期307-311,共5页 Chinese Journal of Neurology
基金 国家自然科学基金资助项目(81171122,81371324) 黑龙江省自然科学基金资助项目(ZD201208) 高等学校博士学科点专项科研基金资助项目(20132307110008)
关键词 重症肌无力 多态性 单核苷酸 CTLA-4抗原 聚合酶链反应 多态性 限制性片段长度 Myasthenia gravis Polymorphism, single nucleotide CTLA-4 antigen Polymerase chain reaction Polymorphism, restriction fragment length
  • 相关文献

参考文献12

  • 1Klein R, Marx A, StrObel P, et al. Autoimmune associations andautoantibody screening show focused recognition in patientsubgroups with generalized myasthenia gravisf J]. Hum Immunol,2013,74(9): 1184-1193. DOI: 10.1016/j. humimm. 2013.06.020.
  • 2Kaya GA, Co§kun AN, Ytlmaz V, et al. The association ofPTPN22 R620W polymorphism is stronger with late-onset AChR-myasthenia gravis in Turkey [ J ]. PLoS One, 2014,9(8):el04760. DOI: 10.1371/joumal. pone. 0104760.
  • 3毛海婷,王雄彪,张玲,顾洪涛.CTLA-4基因多态性在重症肌无力发病机理中的作用[J].中华医学遗传学杂志,2004,21(6):574-578. 被引量:13
  • 4Huang CH, Wei JC, Chen CC, et al. Associations of the PTPN22and CTLA-4 genetic polymorphisms with Taiwan Residents ankylosingspondylitis[J]. Rheumatol Int, 2014,34(5): 683-691. DOI:10.1007/s00296-013-2894-x.
  • 5Wang XB, Pirgkanen R, Giscombe R,et al. Two SNPs in thepromoter region of the CTLA-4 gene affect binding of transcriptionfactors and are associated with human myasthenia gravis [ J]. JIntern Med, 2008,263(1) : 61-69.
  • 6Sun L, Meng Y, Xie Y, et al. CTLA4 variants and haplotypecontribute genetic susceptibility to myasthenia gravis in NorthernChinese population [ J ]. PLoS One, 2014* 9(7): el01986.DOI: 10.1371/joumal. pone. 0101986.
  • 7Kawaguchi N, Kuwabara S, Nemoto Y, et al. Treatment andoutcome of myasthenia gravis : retrospective multi-center analysisof 470 Japanese patients, 1999-2000 [ J]. J Neurol Sci, 2004’224(1:2) : 4347.
  • 8Zheng J, Ibrahim S, Petersen F, et al. Meta-analysis reveals anassociation of PTPN22 C1858T with autoimmune diseases, whichdepends on the localization of the affected tissue [ J ]. GenesImimrn, 2012,13 (8): 641-652. DOI: 10. 1038/gene. 2012.46.
  • 9Lefvert AK, Zhao Y,Ramanujam R, et al. PTPN22 R620Wpromotes production of anti-AChR autoantibodies and IL-2 inmyasthenia gravis [ J]. J Neuroimmunol, 2008,197(2): 110-113. DOI: 10.1016/j.jneuroim.2008.04.004.
  • 10FemAndez-Mestre M, SAnchez K, BalbAs 0, et al. Influence ofCTLA-4 gene polymorphism in autoimmune and infectious diseases[J]. Hum Immunol, 2009, 70(7) : 532- 535. DOI: 10. 1016/j. humimm. 2009.03.016.

二级参考文献1

  • 1Lori L. Hudson,Keith Rocca,Yeong W. Song,Janardan P. Pandey. CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region[J] 2002,Human Genetics(4-5):452~455

共引文献12

同被引文献15

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部